<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04778826</url>
  </required_header>
  <id_info>
    <org_study_id>combined Lobectomy and VAMLA</org_study_id>
    <nct_id>NCT04778826</nct_id>
  </id_info>
  <brief_title>Immune Response Following Lobectomy Along With or Without Bilateral Transcervical Mediastinal Lymphadenectomy</brief_title>
  <official_title>Immune Response of Patients Following Thoracoscopic Lobectomy Along With Bilateral Transcervical Mediastinal Lymphadenectomy and Patients Receiving VATSLOB Together With Standard Unilateral Mediastinal Lymphadenectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Otto Wagner Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic Spine LLC</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Otto Wagner Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Any kind of anatomical lung resection for lung cancer with curative intent has to be&#xD;
      accompanied by formal mediastinal lymph node dissection. Video-assisted mediastinoscopic&#xD;
      lymphadenectomy through a cervical access (VAMLA) along with thoracoscopic lobectomies in the&#xD;
      same setting offers improved radicality through bilateral mediastinal dissection, provide&#xD;
      accurate staging, does not require single lung ventilation and hence ideally supports the&#xD;
      concept of minimally invasive surgery.&#xD;
&#xD;
      Due to the VAMLA associated radicality, the investigator believes that using of VAMLA along&#xD;
      with lobectomy could improve the oncological outcome of lung cancer patients. Furthermore,&#xD;
      the absence of single lung ventilation during VAMLA could attenuate the surgically induced&#xD;
      immunosuppression.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Any kind of anatomical lung resection for lung cancer with curative intent has to be&#xD;
      accompanied by formal mediastinal lymph node dissection. Video-assisted mediastinoscopic&#xD;
      lymphadenectomy through a cervical access (VAMLA) along with thoracoscopic lobectomies in the&#xD;
      same setting offers improved radicality through bilateral mediastinal dissection, provide&#xD;
      accurate staging, does not require single lung ventilation and hence ideally supports the&#xD;
      concept of minimally invasive surgery.&#xD;
&#xD;
      Due to the VAMLA associated radicality, the investigator believes that using VAMLA along with&#xD;
      lobectomy could improve the oncological outcome of lung cancer patients. Furthermore, the&#xD;
      absence of single lung ventilation during VAMLA could attenuate the surgically induced&#xD;
      immunosuppression.&#xD;
&#xD;
      The present study aims at:&#xD;
&#xD;
        1. The current project primarily aims at identifying the effect of reduced single lunge&#xD;
           ventilation time during VAMLA-VATS lobectomy on the intraoperative production of oxygen&#xD;
           radicals as well as its effect on the immune competence of patients undergoing&#xD;
           VAMLA-VATS lobectomy as compared to those receiving VATS lobectomy Along with&#xD;
           conventional unilateral lymphadenectomy.&#xD;
&#xD;
        2. Secondary, in line with the hypothesis that radical bilateral lymphadenectomy might&#xD;
           results in a more complete oncological staging as compared to unilateral lymphadenectomy&#xD;
           or lymph node sampling. The current project aims to compare the pre- and postoperative&#xD;
           staging in patients undergoing VAMLA, as VAMLA enables a proper examination of all&#xD;
           bilateral mediastinal lymph nodes.&#xD;
&#xD;
        3. Patient Follow-up will be continued for at least 5 years postoperatively in order to&#xD;
           compare the oncological outcome namely local and distant recurrence, tumor-associated&#xD;
           and overall survival in patients undergoing VAMLA-VATS Lobectomy as compared to those&#xD;
           with VATS lobectomy. This issue is, however, a second endpoint of this study and will be&#xD;
           independent of the primary endpoint.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2020</start_date>
  <completion_date type="Anticipated">March 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Compare the oncological outcome and immune competence between patients who undergo lung lobectomy with standard lymphadenectomy and those who undergo combined lobectomy and video assisted bilateral mediastinal lymphadenectomy</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative interleukins</measure>
    <time_frame>1st postoperative day</time_frame>
    <description>Interleukin (IL) 6 serum concentration on the 1st postoperative day</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hospitalisation</measure>
    <time_frame>until discharge from hospital, assessed up to 14 days</time_frame>
    <description>Discharge from hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Survival</measure>
    <time_frame>5 years</time_frame>
    <description>5 years survival</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Lung Neoplasm Malignant</condition>
  <arm_group>
    <arm_group_label>Lung Lobectomy with standard ipsilateral lymphadenectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lung lobectomy with ipsilateral lymphadenectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lung Lobectomy with VAMLA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lung lobectomy combined with video-assisted mediastinal lymphadenectomy through the neck (VAMLA). The approach is similar to transcervical mediastinoscopy and allows for a radical bloc dissection of all mediastinal lymph node stations. Besides the benefit of bilateral lung ventilation during this phase of the operation a bilateral mediastinal lymphadenectomy offers improved surgical radicality.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Lymphadenectomy</intervention_name>
    <description>radical bloc dissection of all mediastinal lymph node stations</description>
    <arm_group_label>Lung Lobectomy with VAMLA</arm_group_label>
    <arm_group_label>Lung Lobectomy with standard ipsilateral lymphadenectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  adult&#xD;
&#xD;
          -  non small cell lung cancer&#xD;
&#xD;
          -  operable tumor&#xD;
&#xD;
          -  indicated for endoscopic lung surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Micheal Mueller, MD</last_name>
    <role>Study Director</role>
    <affiliation>Department of thoracic Surgery, Clinic Floridsdorf</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mohamed SALAMA, MD, PhD</last_name>
    <phone>+4312770074221</phone>
    <email>mohamed.salama@meduniwien.ac.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Micheal Mueller, MD</last_name>
    <phone>+4312770074201</phone>
    <email>micheal.mueller@wienkav.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Thoracic Surgery, clinic Floridsdorf</name>
      <address>
        <city>Vienna</city>
        <zip>1210</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohamed Salama, MD, PhD</last_name>
      <email>mohamed.salama@meduniwien.ac.at</email>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>October 15, 2020</study_first_submitted>
  <study_first_submitted_qc>March 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 3, 2021</study_first_posted>
  <last_update_submitted>March 2, 2021</last_update_submitted>
  <last_update_submitted_qc>March 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Otto Wagner Hospital</investigator_affiliation>
    <investigator_full_name>Mohamed Salama</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>lung lobectomy</keyword>
  <keyword>lymphadenectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

